Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw an uptick in trading volume on Monday. 537,087 shares were traded during mid-day trading, an increase of 470% from the average daily volume of 94,300 shares. The stock last traded at $32.88 and had previously closed at $33.07.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the company. Zacks Research upgraded Merck KGaA from a “strong sell” rating to a “hold” rating in a report on Tuesday, November 10th. UBS Group downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six equities research analysts have rated the stock with a Hold rating. According to MarketBeat, the company has an average rating of “Hold”.
Check Out Our Latest Stock Analysis on MKKGY
Merck KGaA Stock Performance
Merck KGaA Company Profile
Merck KGaA is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility.
See Also
- Five stocks we like better than Merck KGaA
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
- SpaceX’s Wild Ride Puts 2 Space Stocks and a Weekly-Payout ETF in Focus
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
